"Global Demand Outlook for Executive Summary Carcinoembryonic Antigen (CEA) Market Size and Share Data Bridge Market Research analyses that the carcinoembryonic antigen (CEA) market which was USD 1,855.41 million in 2021, is expected to reach USD 2,912.90 million by 2029, at a CAGR of 5.80% during the forecast period 2022 to 2029. Carcinoembryonic Antigen (CEA) Market research reports consist...

Carcinoembryonic antigen (CEA) is a glycoprotein belonging to the immunoglobulin superfamily, normally expressed at very low levels in healthy adult tissues but significantly elevated in certain malignancies. It serves as a widely used tumor marker for monitoring disease progression, recurrence, and treatment response, primarily in colorectal cancer, but also in breast, lung, pancreatic,...

Executive Summary:  The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...

"Executive Summary Carcinoembryonic Antigen (CEA) Market Size and Share Across Top Segments Data Bridge Market Research analyses that the carcinoembryonic antigen (CEA) market which was USD 1,855.41 million in 2021, is expected to reach USD 2,912.90 million by 2029, at a CAGR of 5.80% during the forecast period 2022 to 2029. By utilizing few steps or a number of steps, the process of...